Suitability of rifampicin for intermittent administration in the treatment of tuberculosis.
D000704:Analysis of Variance; D000818:Animals; D004352:Drug Resistance, Microbial; D006168:Guinea Pigs; D007538:Isoniazid / Q000494:pharmacology; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification; D012293:Rifampin / Q000008:administration & dosage* / Q000097:blood / Q000494:pharmacology; D013154:Spleen / Q000382:microbiology; D013307:Streptomycin / Q000494:pharmacology; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology; D014386:Tuberculosis, Hepatic / Q000188:drug therapy
D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin